Purchase Short-Term Access
Efficacy and Toxicity of Single Daily Doses of Amikacin and Ceftriaxone versus Multiple Daily Doses of Amikacin and Ceftazidime for Infection in Patients with Cancer and Granulocytopenia
The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer.
Annals of Internal Medicine 1993;119:584-593.
doi:10.7326/0003-4819-119-7_Part_1-199310010-00006
Purchase Online access to this article for 24 hours
